Avania, a unique CRO that advances the research of medical devices, novel technology, and combination products across a range of therapeutic specialties, agreed to acquire IMARC, a well-respected medical device CRO company. Financial terms were not disclosed. “At Avania, we are focused on building a high-quality, full-service specialist medical technology CRO with global reach. We are delighted to welcome the IMARC team, with whom we have had the pleasure of collaborating for some time. They bring a great commitment to client service and outcomes and allow us to offer our clients additional depth and strength in the US, complementing our existing global operations perfectly," Sapna Hornyak, Avania CEO.